Arokiaswamy Velumani
CEO @ Nueclear Healthcare
Mumbai, India
Arokiaswamy Velumani is a seed investor at Nueclear Healthcare in Mumbai focused on Manufacturing and Transportation. Arokiaswamy Velumani is the Founder and CEO at Nueclear Healthcare. Dr. Velumani proves amply clearly to an industry that, “Focus gives Success”. Born in a small village near Coimbatore, South India, to a landless farmer, today he owns and operates this Industry leader, Thyrocare, a brand worth over Rs. 2000 crores. Began as a mathematician, hebecame a Pathologist after his Ph.D. in Microbiology from BARC/ Mumbai University in Thyroid Biochemistry. As a Research Scientist and Teacher, he worked for 14 years in BARC, and then in Business, he has become an administrator. An infecting motivator, he has succeeded in converting educated as employable, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealth creators, and of course by his unique way of transforming intimidating problems into opportunities for prosperity.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Arokiaswamy Velumani invests in
Stages Arokiaswamy Velumani invests in
Countries Arokiaswamy Velumani invests in
Round sizes
Round size
- Seed
- $601k–$1.7M
Investment Focus
Industry
- Manufacturing 2 (25%)
- Transportation 2 (25%)
- Rental 1 (13%)
- Retail 1 (13%)
- Robotics 1 (13%)
Stage
- Seed 3 (38%)
- Pre-Seed 1 (13%)
- Series B 1 (13%)
- Series F 1 (13%)
- Funding Round 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Avni
|
Avni is a women's health and wellness brand that draws inspiration from both grandmothers and Ayurvedic practices. They provide a variety of innovative menstrual products that are toxin-free and designed with consciousness in mind. Not only are these products appropriate for women of all ages, body types, and menstrual cycles, but they arealso handcrafted by rural women. Avni also provides India's first 24-hour PeriodHelpline, which is managed by healthcare professionals. Women can get answers to their health-related questions via WhatsApp, phone calls, or SMS. Women can feel confident and supported during their menstrual cycle with Avni. | $420.4K / Seed / Jul 08, 2026 | |
Simple Energy
|
Simple Energy specializes in the manufacture of smart electric two-wheelers. Simply Energy consists of a young 100+ member team of EV enthusiasts, designers, engineers, and problem-solvers coming together to make smart, supercharging, and affordable two-wheelers. The company was founded in 2019 and is based in Bangalore, India. | $13.4M / Series B / Jun 01, 2026 | |
REGRIP
|
Regrip tyres are a high-performance alternative to fresh tyres for big commercial vehicles' dummies and drive axles. Regrip's inexpensive, dependable, and ecological product line assists fleet owners in saving significant money on tyre use. | $1.7M / Seed / Jan 30, 2026 | |
Cosmoserve Space
|
Cosmoserve Space is developing autonomous robotic spacecraft to mitigate the rapidly growing problem of orbital debris. | $600.5K / Seed / Jan 22, 2026 | |
Hala Mobility
|
Hala Mobility is a provider of a multi-modal ride-sharing platform for e-commerce businesses and gig workers. The company's offerings include a comprehensive app that manages electric vehicles, batteries, and drivers, alongside a fleet of electric two-wheelers. | $1.3M / Jan 20, 2026 | |
Aloe E-Cell
|
Aloe Ecell is a company that uses natural elements to power everyday device. Aloe Ecell make 1.5 V Liquid cell batteries out of Aloe Vera. | $275.1K / Pre-Seed / Jan 17, 2026 | |
|
Simple Energy
|
Simple Energy specializes in the manufacture of smart electric two-wheelers. Simply Energy consists of a young 100+ member team of EV enthusiasts, designers, engineers, and problem-solvers coming together to make smart, supercharging, and affordable two-wheelers. The company was founded in 2019 and is based in Bangalore, India. | $20M / Convertible Note / Feb 07, 2023 | |
PharmEasy
|
PharmEasy is a health tech startup offering services such as teleconsultation, medicine deliveries, and diagnostic test sample collections.It also operates an online pharmacy that helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. The startup company is funded and backed byCaisse de Dépôt et Placement du Québec (CDPQ), Ascent Health, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, InnoVen Capital, and Temasek Holdings.PharmEasy was founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. | $500M / Series F / Jul 07, 2021 |
Co-Investors
B Capital
1 deal together
Kotak Realty Fund
1 deal together
Orios Venture Partners
1 deal together
Prosus Ventures
1 deal together
About Nueclear Healthcare
Founded in 2010, Nueclear Healthcare Limited is a 100% subsidiary of Thyrocare Technologies Limited. NHL is a market leader in PET/CT imaging in India and is creating a highly disruptive model to completely change the status quo in India. Led by Dr. A Velumani, it is creating a pan Indian network of PET/CT facilities through a first ofits kind model in the world.
Nueclear Healthcare Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Arokiaswamy Velumani invest in?
Arokiaswamy Velumani invests primarily in Manufacturing, Transportation and Rental startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Arokiaswamy Velumani's check size?
Arokiaswamy Velumani typically joins rounds of $601k–$1.7M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Arokiaswamy Velumani participates in.
When did Arokiaswamy Velumani last invest?
The most recent investment recorded for Arokiaswamy Velumani closed in Jul 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
